Connect with us

National

Could virosome-based nanovaccines be a promising new approach to preventing viral diseases? – News-Medical.Net

A recent review in the International Journal of Biological Macromolecules provides a novel overview of ‘virosome’-based nanovaccine production, its properties,…

Published

on

Article feature image

A recent review in the International Journal of Biological Macromolecules provides a novel overview of ‘virosome’-based nanovaccine production, its properties, and its application in viral diseases, emphasizing its importance in SARS-CoV-2 vaccine discovery.
Virosome is a lipidic nanomaterial and is biomimetic. It can act as an immunogen, epitope-displaying nanocarrier, or delivery nanoplatform.
Virosome mimics the enveloped virus fusion pathway to evoke potent humoral and cellular immune responses.”

Click here to view the original article.